Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Angiodynamics (ANGO) Other Gross PP&E Adjustments (2016 - 2026)

Angiodynamics' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at -$8.1 million for Q1 2026.

  • For Q1 2026, Other Gross PP&E Adjustments fell 17.17% year-over-year to -$8.1 million; the TTM value through Feb 2026 reached -$8.1 million, down 17.17%, while the annual FY2025 figure was -$6.9 million, 8.08% up from the prior year.
  • Other Gross PP&E Adjustments reached -$8.1 million in Q1 2026 per ANGO's latest filing, up from -$11.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $93.0 million in Q2 2023 to a low of -$20.5 million in Q3 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $583176.5, with a median of -$11.0 million recorded in 2025.
  • The largest YoY upside for Other Gross PP&E Adjustments was 41.61% in 2024 against a maximum downside of 108.01% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$15.0 million in 2022, then rose by 24.6% to -$11.3 million in 2023, then grew by 11.61% to -$10.0 million in 2024, then dropped by 10.1% to -$11.0 million in 2025, then grew by 26.46% to -$8.1 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Other Gross PP&E Adjustments are -$8.1 million (Q1 2026), -$11.0 million (Q4 2025), and -$11.2 million (Q3 2025).